ABL-kinase domain point mutation as a cause of imatinib (STI571) resistance in CML patient who progress to myeloid blast crisis
Titel:
ABL-kinase domain point mutation as a cause of imatinib (STI571) resistance in CML patient who progress to myeloid blast crisis
Auteur:
Sacha, Tomasz Hochhaus, Andreas Hanfstein, Benjamin Müller, Martin C. Rudzki, Zbigniew Czopek, Jacek Wolska-Smoleń, Teresa Czekalska, Sylwia Salamanchuk, Zoriana Jakóbczyk, Małgorzata Skotnicki, Aleksander B.